New Sermorelin oral capsules are now available.
Explore SermorelinOnce-daily topical solution
Four coordinated actives. One measured dropper.
A compounded topical solution combining finasteride, fluocinolone acetonide, minoxidil, and tretinoin with vitamin E for eligible patients.
Prescription required · Provider approval required · Results vary
Understand the path
Clinical context.
Real-life rhythm.
FolliSync is applied directly to areas of thinning with a measured dropper. Its multi-ingredient formula is designed to address DHT, follicle activity, scalp inflammation, and topical absorption in one provider-directed routine.
Finasteride 0.25%
Targets local DHT activity at the follicle level.
Fluocinolone acetonide 0.01%
A topical corticosteroid included for scalp inflammation.
Minoxidil 5%
Supports follicle activity and the hair-growth cycle.
Tretinoin 0.01% with vitamin E
Completes the compounded topical formula described in the client brief.
Published pricing
Know the range.
Final treatment, strength, supply, and price depend on provider approval. Published prices may change.
- 30-day supply$189
Consultation and discreet delivery included
Possible effects+
- Scalp dryness, redness, itching, or irritation
- Unwanted facial or body hair
- Dizziness, headache, or blood-pressure changes
- Skin sensitivity from tretinoin
- Finasteride-related sexual side effects may occur
Screening considerations+
- Pregnancy or possibility of pregnancy
- Scalp conditions or broken skin
- Heart or blood-pressure conditions
- Current topical or oral medications
- History of corticosteroid sensitivity
How do I apply FolliSync?+
Apply 1 mL once daily to a clean, dry scalp in the areas directed by your prescription. Massage gently, wash your hands, and leave it on for at least four hours before washing or swimming.
Why does the formula include tretinoin?+
Tretinoin may improve topical penetration and minoxidil activation. It can also increase skin sensitivity, so use only as directed.
When might I notice a change?+
The client brief notes that reduced shedding may be noticed in four to eight weeks and visible density changes may begin around months three to six. Individual results vary.
Compounded medications require a valid prescription and are not reviewed or approved by the FDA as finished drug products for safety, effectiveness, or quality. Body Forward coordinates care and does not manufacture medication.
Other directions
02
03